Skip to main content
logo
Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.000
-0.050 (-2.44%)
At close: Sep 11, 2026, 4:00 PM EDT
2.030
+0.030 (1.50%)
After-hours: Sep 11, 2026, 7:58 PM EDT

Compass Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--0.85---
Revenue Growth
------
Gross Profit
--0.85---
Selling, General & Admin
21.6216.8715.1312.2411.6610.93
Research & Development
59.4655.9742.3438.123020.34
Operating Expenses
81.0972.8457.4850.3641.6631.26
Operating Income
-81.09-72.84-56.63-50.36-41.66-31.26
Interest Expense
------0.37
Interest & Investment Income
7.646.357.257.872.360.03
EBT Excluding Unusual Items
-73.45-66.49-49.38-42.49-39.3-31.61
Gain (Loss) on Sale of Assets
----0.070.04
Pretax Income
-73.45-66.49-49.38-42.49-39.23-82.18
Net Income
-73.45-66.49-49.38-42.49-39.23-82.18
Net Income to Common
-73.45-66.49-49.38-42.49-39.23-82.18
Net Income Growth
------
Shares Outstanding (Basic)
18215813712710563
Shares Outstanding (Diluted)
18215813712710563
Shares Change
31.82%14.78%8.15%20.76%67.31%104.28%
EPS (Basic)
-0.40-0.42-0.36-0.33-0.37-1.31
EPS (Diluted)
-0.40-0.42-0.36-0.33-0.37-1.31
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-56.38-49.17-44.9-40.65-34.34-21.55
Free Cash Flow Per Share
-0.31-0.31-0.33-0.32-0.33-0.34
Gross Margin
--100.00%---
Operating Margin
---6661.76%---
Profit Margin
---5808.82%---
Free Cash Flow Margin
---5282.23%---
EBITDA
-81.01-72.56-56.04-49.66-40.87-30.7
D&A For EBITDA
0.070.280.590.70.780.57
EBIT
-81.09-72.84-56.63-50.36-41.66-31.26
SEC Filings: 10-K · 10-Q